Literature DB >> 10807506

The liver as a site of T-cell apoptosis: graveyard, or killing field?

I N Crispe1, T Dao, K Klugewitz, W Z Mehal, D P Metz.   

Abstract

The liver is a site at which apoptotic CD8+ cells accumulate during the clearance phase of peripheral immune responses. Normal mouse liver contains an unusual mixture of lymphocytes in which natural killer (NK) and NK-T cells are abundant and apoptotic T cells are present, and we interpret these cell populations as, respectively, agents and targets of an intrahepatic T-cell trapping and killing mechanism. In support of this idea, direct perfusion of activated lymphocyte populations through the normal liver results in the selective retention of activated CD8+ T cells. T cells trapped in this manner undergo apoptosis in the liver. This mechanism could explain the importance of the liver in oral tolerance, the phenomenon of tolerance induced by portal vein infusion of antigenic cells, the tolerance to allogeneic liver allografts, and the persistence of some liver pathogens including hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807506     DOI: 10.1034/j.1600-0528.2002.017412.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  94 in total

1.  Apoptosis-inducing protein derived from hepatocyte selectively induces apoptosis in lymphocytes.

Authors:  Masanobu Ikeda; Hideshi Yoshikawa; Jie Liu; Yasuo Nakajima; Yoshihiro Akahane; Kachio Tasaka
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

2.  Peripheral immunization induces functional intrahepatic hepatitis C specific immunity following selective retention of vaccine-specific CD8 T cells by the liver.

Authors:  Krystle A Lang Kuhs; Roberta Toporovski; Arielle A Ginsberg; Abby L Olsen; Devon J Shedlock; Matthew P Morrow; Jian Yan; Rebecca G Wells; David B Weiner
Journal:  Hum Vaccin       Date:  2011-12-01

Review 3.  T-cell migration: a naive paradigm?

Authors:  Stephen Cose
Journal:  Immunology       Date:  2007-01       Impact factor: 7.397

4.  Role of CD44 and its v7 isoform in staphylococcal enterotoxin B-induced toxic shock: CD44 deficiency on hepatic mononuclear cells leads to reduced activation-induced apoptosis that results in increased liver damage.

Authors:  Robert J McKallip; Michael Fisher; Ursula Gunthert; Andras K Szakal; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection.

Authors:  C B Bigger; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  The role of apoptosis in immune hyporesponsiveness following AAV8 liver gene transfer.

Authors:  Susan M Faust; Peter Bell; Yanqing Zhu; Julio Sanmiguel; James M Wilson
Journal:  Mol Ther       Date:  2013-10-15       Impact factor: 11.454

Review 7.  Mechanisms of drug-induced liver injury.

Authors:  Michael P Holt; Cynthia Ju
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

Review 8.  Hepatitis C virus and ethanol alter antigen presentation in liver cells.

Authors:  Natalia A Osna
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

9.  Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection.

Authors:  Henry Radziewicz; Chris C Ibegbu; Huiming Hon; Melissa K Osborn; Kamil Obideen; Mohammad Wehbi; Gordon J Freeman; Jeffrey L Lennox; Kimberly A Workowski; Holly L Hanson; Arash Grakoui
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

10.  Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.

Authors:  Kazuhito Kawata; Guo-Xiang Yang; Yugo Ando; Hajime Tanaka; Weici Zhang; Yoshimasa Kobayashi; Koichi Tsuneyama; Patrick S C Leung; Zhe-Xiong Lian; William M Ridgway; Aftab A Ansari; Xiao-Song He; M Eric Gershwin
Journal:  Hepatology       Date:  2013-07-24       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.